Thermo Fisher lung cancer test wins expanded approval in Japan - MedTech Dive

Thermo Fisher lung cancer test wins expanded approval in Japan  MedTech Dive

Thermo Fisher Scientific said it has received expanded approval in Japan for its companion diagnostic test for non-small cell lung cancer (NSCLC) therapies.



Comments

Popular posts from this blog

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...

Oncology: The disease, dynamics & challenges of market research

Respirology | APSR Respiratory Medicine Journal